{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:51:56Z","timestamp":1779922316155,"version":"3.53.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Clinical therapy research in the specialist health services","award":["2017204"],"award-info":[{"award-number":["2017204"]}]},{"name":"Clinical therapy research in the specialist health services","award":["2017204"],"award-info":[{"award-number":["2017204"]}]},{"name":"Center for Crisis Psychology at the University of Bergen"},{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Bergen 4-day treatment (B4DT) is a concentrated exposure-based therapy that has been shown to be effective in the treatment of anxiety disorders. The current study sought to examine the effectiveness of B4DT for panic disorder (PD), when delivered with a combination of face-to-face sessions and videoconferencing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Treatment was delivered to 50 patients from April 2020 to May 2021. Because of regulations during the pandemic, a significant portion of the treatment was conducted via videoconference. The primary outcome measure was the clinician-rated Panic Disorder Severity Scale (PDSS), and secondary measures included patient-rated symptoms of panic disorder, agoraphobia, generalized anxiety, depression, and treatment satisfaction. Changes in symptom levels over time were estimated using multilevel models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients showed a significant reduction in clinician-rated symptoms of panic disorder (Measured by PDSS) from before treatment to post treatment (d\u2009=\u20092.18) and 3-month follow-up (d\u2009=\u20092.01). At three months follow-up 62% of patients were classified as in remission, while 70% reported a clinically significant response. We also found a reduction in symptoms of depression and generalized anxiety, and the patients reported high satisfaction with the treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The current study suggests that B4DT delivered in a combination of videoconference and face-to-face meetings may be a useful treatment approach. As the study is uncontrolled, future studies should also include more strictly designed investigations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-023-05062-7","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T02:01:47Z","timestamp":1691460107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities"],"prefix":"10.1186","volume":"23","author":[{"given":"Kay Morten","family":"Hjelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorstein Olsen","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Lillevik","family":"Thorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Kvale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar","family":"Snorrason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thr\u00f6stur","family":"Bj\u00f6rgvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"5062_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC2013","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"4","key":"5062_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0005-7967(86)90011-2","volume":"24","author":"DM Clark","year":"1986","unstructured":"Clark DM. A cognitive approach to panic. Behav Res Ther. 1986;24(4):461\u201370.","journal-title":"Behav Res Ther"},{"issue":"4","key":"5062_CR3","first-page":"415","volume":"63","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. JAMA Psychiat. 2006;63(4):415\u201324.","journal-title":"JAMA Psychiat"},{"issue":"10063","key":"5062_CR4","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/S0140-6736(16)30381-6","volume":"388","author":"MG Craske","year":"2016","unstructured":"Craske MG, Stein MB. Anxiety Lancet. 2016;388(10063):3048\u201359.","journal-title":"Anxiety Lancet"},{"issue":"12","key":"5062_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1017\/S0033291717003919","volume":"48","author":"A Pompoli","year":"2018","unstructured":"Pompoli A, Furukawa TA, Efthimiou O, Imai H, Tajika A, Salanti G. Dismantling cognitive-behaviour therapy for panic disorder: a systematic review and component network meta-analysis. Psychol Med. 2018;48(12):1945\u201353.","journal-title":"Psychol Med"},{"issue":"2","key":"5062_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1037\/gdn0000064","volume":"21","author":"D Schwartze","year":"2017","unstructured":"Schwartze D, Barkowski S, Strauss B, Burlingame GM, Barth J, Rosendahl J. Efficacy of group psychotherapy for panic disorder: Meta-analysis of randomized, controlled trials. Group Dyn Theory Res Pract. 2017;21(2):77.","journal-title":"Group Dyn Theory Res Pract"},{"key":"5062_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brat.2017.07.008","volume":"97","author":"LG \u00d6st","year":"2017","unstructured":"\u00d6st LG, Ollendick TH. Brief, intensive and concentrated cognitive behavioral treatments for anxiety disorders in children: A systematic review and meta-analysis. Behav Res Ther. 2017;97:134\u201345.","journal-title":"Behav Res Ther"},{"issue":"4","key":"5062_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/16506073.2019.1628808","volume":"49","author":"EP Stech","year":"2020","unstructured":"Stech EP, Lim J, Upton EL, Newby JM. Internet-delivered cognitive behavioral therapy for panic disorder with or without agoraphobia: a systematic review and meta-analysis. Cogn Behav Ther. 2020;49(4):270\u201393.","journal-title":"Cogn Behav Ther"},{"issue":"6","key":"5062_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.brat.2005.05.008","volume":"44","author":"B Deacon","year":"2006","unstructured":"Deacon B, Abramowitz J. A pilot study of two-day cognitive-behavioral therapy for panic disorder. Behav Res Ther. 2006;44(6):807\u201317.","journal-title":"Behav Res Ther"},{"key":"5062_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jad.2014.11.029","volume":"174","author":"IJ Knuts","year":"2015","unstructured":"Knuts IJ, Esquivel G, Overbeek T, Schruers KR. Intensive behavioral therapy for agoraphobia. J Affect Disord. 2015;174:19\u201322.","journal-title":"J Affect Disord"},{"issue":"4","key":"5062_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/07317107.2012.732873","volume":"34","author":"RM Chase","year":"2012","unstructured":"Chase RM, Whitton SW, Pincus DB. Treatment of adolescent panic disorder: A nonrandomized comparison of intensive versus weekly CBT. Child Fam Behav Ther. 2012;34(4):305\u201323.","journal-title":"Child Fam Behav Ther"},{"key":"5062_CR12","doi-asserted-by":"publisher","first-page":"100267","DOI":"10.1016\/j.jadr.2021.100267","volume":"6","author":"KC Remmerswaal","year":"2021","unstructured":"Remmerswaal KC, Lans L, Seldenrijk A, Hoogendoorn AW, van Balkom AJ, Batelaan NM. Effectiveness and feasibility of intensive versus regular cognitive behaviour therapy in patients with anxiety and obsessive-compulsive disorders: a meta-analysis. J Affect Disord Reports. 2021;6:100267.","journal-title":"J Affect Disord Reports"},{"issue":"8","key":"5062_CR13","doi-asserted-by":"publisher","first-page":"e2013249","DOI":"10.1001\/jamanetworkopen.2020.13249","volume":"3","author":"G Kvale","year":"2020","unstructured":"Kvale G, Hansen B, Hagen K, Abramowitz JS, B\u00f8rtveit T, Craske MG, et al. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(8):e2013249.","journal-title":"JAMA Netw Open"},{"key":"5062_CR14","doi-asserted-by":"crossref","unstructured":"Hansen B, Hagen K, \u00d6st L-G, Solem S, Kvale G. The Bergen 4-Day OCD Treatment Delivered in a Group Setting: 12-Month Follow-Up. Front Psychol. 2018;9.","DOI":"10.3389\/fpsyg.2018.00639"},{"issue":"2","key":"5062_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/16506073.2018.1478447","volume":"48","author":"B Hansen","year":"2019","unstructured":"Hansen B, Kvale G, Hagen K, Havnen A, \u00d6st L-G. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting. Cogn Behav Ther. 2019;48(2):89\u2013105.","journal-title":"Cogn Behav Ther"},{"key":"5062_CR16","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3389\/fpsyg.2019.02500","volume":"10","author":"G Launes","year":"2019","unstructured":"Launes G, Hagen K, Sunde T, \u00d6st L-G, Klovning I, Laukvik I-L, et al. A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Front Psychol. 2019;10:2500.","journal-title":"Front Psychol"},{"key":"5062_CR17","doi-asserted-by":"crossref","unstructured":"Kvale G, Hansen B, Bj\u00f6rgvinsson T, B\u00f8rtveit T, Hagen K, Haseth S, et al. Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment. BMC Psychiatry. 2018;18(1).","DOI":"10.1186\/s12888-018-1887-4"},{"key":"5062_CR18","doi-asserted-by":"crossref","unstructured":"Hansen B, Kvale G, Hagen K, Hjelle KM, Solem S, B\u00f8 B, et al. The Bergen 4-Day Treatment for Panic Disorder: A Pilot Study. Front Psychol. 2018;9.","DOI":"10.3389\/fpsyg.2018.01044"},{"key":"5062_CR19","doi-asserted-by":"crossref","unstructured":"Iversen HM, Eide TO, Harvold M, Solem S, Kvale G, Hansen B, et al. The Bergen 4-day treatment for panic disorder: replication and implementation in a new clinic. BMC Psychiatry. 2022;22(1).","DOI":"10.1186\/s12888-022-04380-6"},{"key":"5062_CR20","doi-asserted-by":"crossref","unstructured":"Eide TO, Hjelle KM, S\u00e6tre I, Solem S, Olsen T, Sk\u00f8ld RO, et al. The Bergen 4-day treatment for panic disorder: implementation in a rural clinical setting. BMC Psychiatry. 2023;23(1):1\u20138.","DOI":"10.1186\/s12888-023-04812-x"},{"key":"5062_CR21","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22\u201333;quiz 4\u201357."},{"issue":"3","key":"5062_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.eurpsy.2009.02.004","volume":"25","author":"J Mordal","year":"2010","unstructured":"Mordal J, Gundersen O, Bramness JG. Norwegian version of the Mini-International Neuropsychiatric Interview: feasibility, acceptability and test-retest reliability in an acute psychiatric ward. Eur Psychiatry. 2010;25(3):172\u20137.","journal-title":"Eur Psychiatry"},{"issue":"3","key":"5062_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/cpp.703","volume":"18","author":"LA Wuyek","year":"2011","unstructured":"Wuyek LA, Antony MM, McCabe RE. Psychometric properties of the panic disorder severity scale: clinician-administered and self-report versions. Clin Psychol Psychother. 2011;18(3):234\u201343.","journal-title":"Clin Psychol Psychother"},{"issue":"5","key":"5062_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0022-3956(01)00028-0","volume":"35","author":"MK Shear","year":"2001","unstructured":"Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J, et al. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res. 2001;35(5):293\u20136.","journal-title":"J Psychiatr Res"},{"issue":"10","key":"5062_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/da.20532","volume":"26","author":"TA Furukawa","year":"2009","unstructured":"Furukawa TA, Katherine Shear M, Barlow DH, Gorman JM, Woods SW, Money R, et al. Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depress Anxiety. 2009;26(10):922\u20139.","journal-title":"Depress Anxiety"},{"issue":"6","key":"5062_CR26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1037\/0022-006X.52.6.1090","volume":"52","author":"DL Chambless","year":"1984","unstructured":"Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol. 1984;52(6):1090\u20137.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"5062_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0005-7967(85)90140-8","volume":"23","author":"DL Chambless","year":"1985","unstructured":"Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C. The Mobility Inventory for Agoraphobia. Behav Res Ther. 1985;23(1):35\u201344.","journal-title":"Behav Res Ther"},{"issue":"4","key":"5062_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.beth.2011.03.001","volume":"42","author":"DL Chambless","year":"2011","unstructured":"Chambless DL, Sharpless BA, Rodriguez D, McCarthy KS, Milrod BL, Khalsa S-R, et al. Psychometric properties of the mobility inventory for agoraphobia: convergent, discriminant, and criterion-related validity. Behav Ther. 2011;42(4):689\u201399.","journal-title":"Behav Ther"},{"key":"5062_CR29","doi-asserted-by":"crossref","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. SLACK Incorporated Thorofare, NJ; 2002. p. 509\u201315.","DOI":"10.3928\/0048-5713-20020901-06"},{"issue":"10","key":"5062_CR30","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"3","key":"5062_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0149-7189(79)90094-6","volume":"2","author":"DL Larsen","year":"1979","unstructured":"Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client\/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197\u2013207.","journal-title":"Eval Program Plann"},{"key":"5062_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1192\/bjp.180.5.461","volume":"180","author":"JC Mundt","year":"2002","unstructured":"Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461\u20134.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"5062_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.comppsych.2004.08.007","volume":"46","author":"D Mataix-Cols","year":"2005","unstructured":"Mataix-Cols D, Cowley AJ, Hankins M, Schneider A, Bachofen M, Kenwright M, et al. Reliability and validity of the work and social adjustment scale in phobic disorders. Compr Psychiatry. 2005;46(3):223\u20138.","journal-title":"Compr Psychiatry"},{"issue":"4\u20135","key":"5062_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/10503300802641444","volume":"19","author":"GA Tasca","year":"2009","unstructured":"Tasca GA, Gallop R. Multilevel modeling of longitudinal data for psychotherapy researchers: I. The basics Psychother Res. 2009;19(4\u20135):429\u201337.","journal-title":"The basics Psychother Res"},{"issue":"4\u20135","key":"5062_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/10503300902849475","volume":"19","author":"R Gallop","year":"2009","unstructured":"Gallop R, Tasca GA. Multilevel modeling of longitudinal data for psychotherapy researchers: II. The complexities Psychother Res. 2009;19(4\u20135):438\u201352.","journal-title":"The complexities Psychother Res"},{"issue":"1","key":"5062_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1037\/1082-989X.7.1.105","volume":"7","author":"SB Morris","year":"2002","unstructured":"Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods. 2002;7(1):105\u201325.","journal-title":"Psychol Methods"},{"issue":"1","key":"5062_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/08039488.2018.1554699","volume":"73","author":"M Svensson","year":"2019","unstructured":"Svensson M, Nilsson T, Johansson H, Viborg G, Perrin S, Sandell R. Psychometric analysis of the Swedish panic disorder severity scale and its self-report version. Nord J Psychiatry. 2019;73(1):58\u201363.","journal-title":"Nord J Psychiatry"},{"key":"5062_CR38","doi-asserted-by":"crossref","unstructured":"Hawes MT, Szenczy AK, Klein DN, Hajcak G, Nelson BD. Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic. Psychol Med. 2021:1\u20139.","DOI":"10.1017\/S0033291720005358"},{"issue":"4","key":"5062_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/pubmed\/fdaa106","volume":"42","author":"A B\u00e4uerle","year":"2020","unstructured":"B\u00e4uerle A, Teufel M, Musche V, Weism\u00fcller B, Kohler H, Hetkamp M, et al. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Public Health (Oxf). 2020;42(4):672\u20138.","journal-title":"J Public Health (Oxf)"},{"key":"5062_CR40","doi-asserted-by":"publisher","first-page":"103530","DOI":"10.1016\/j.resp.2020.103530","volume":"282","author":"H Javelot","year":"2020","unstructured":"Javelot H, Weiner L, Hingray C, Freire RC, Nardi AE. COVID-19 and its psychological consequences: Beware of the respiratory subtype of panic disorder. Respir Physiol Neurobiol. 2020;282:103530.","journal-title":"Respir Physiol Neurobiol"},{"key":"5062_CR41","doi-asserted-by":"crossref","unstructured":"Launes G, Hagen K, \u00d6st L-G, Solem S, Hansen B, Kvale G. The Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive Disorder: Outcomes for Patients Treated After Initial Waiting List or Self-Help Intervention. Front Psychol. 2020;11.","DOI":"10.3389\/fpsyg.2020.00982"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-05062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-05062-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-05062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T09:18:59Z","timestamp":1700471939000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-05062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5062"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-05062-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was ethically approved by REK-midt (ID 468517), and all methods were performed in accordance with relevant guidelines and regulations. All patients signed written consent for participation and were informed that they could withdraw the consent at any time without giving any reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"570"}}